Matches in Nanopublications for { ?s ?p "[Results show that breast cancer development is characterized by either nuclear loss or cytoplasmic translocation of CITED4, with consequent loss of hypoxia-inducible factor-1alpha transcriptional antagonist activity.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ?g. }
Showing items 1 to 8 of
8
with 100 items per page.
- NP107396.RAiJMMucDCVPZb56I6JA3V3ACMWYD35wqn-TxgL5YvSDg130_assertion description "[Results show that breast cancer development is characterized by either nuclear loss or cytoplasmic translocation of CITED4, with consequent loss of hypoxia-inducible factor-1alpha transcriptional antagonist activity.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP107396.RAiJMMucDCVPZb56I6JA3V3ACMWYD35wqn-TxgL5YvSDg130_provenance.
- NP108188.RAxu1FDHIgunxLbAj0DXjtRu8AjTFXRpD2MlVPjQbOs6M130_assertion description "[Results show that breast cancer development is characterized by either nuclear loss or cytoplasmic translocation of CITED4, with consequent loss of hypoxia-inducible factor-1alpha transcriptional antagonist activity.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP108188.RAxu1FDHIgunxLbAj0DXjtRu8AjTFXRpD2MlVPjQbOs6M130_provenance.
- NP206658.RADPWgqlciTlyQJfMIg24GkiTc77bJggyVhrSPqUVkhqc130_assertion description "[Results show that breast cancer development is characterized by either nuclear loss or cytoplasmic translocation of CITED4, with consequent loss of hypoxia-inducible factor-1alpha transcriptional antagonist activity.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP206658.RADPWgqlciTlyQJfMIg24GkiTc77bJggyVhrSPqUVkhqc130_provenance.
- assertion description "[Results show that breast cancer development is characterized by either nuclear loss or cytoplasmic translocation of CITED4, with consequent loss of hypoxia-inducible factor-1alpha transcriptional antagonist activity.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- NP171402.RANh2ofFpeKigVCPiIacTxNo9BvGAXs-qR2EzbR4bwNIM130_assertion description "[Results show that breast cancer development is characterized by either nuclear loss or cytoplasmic translocation of CITED4, with consequent loss of hypoxia-inducible factor-1alpha transcriptional antagonist activity.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP171402.RANh2ofFpeKigVCPiIacTxNo9BvGAXs-qR2EzbR4bwNIM130_provenance.
- NP170611.RAv31avUsHRXyLBVfESsCgY9_yh_nruMy2KyBQ0mRnd38130_assertion description "[Results show that breast cancer development is characterized by either nuclear loss or cytoplasmic translocation of CITED4, with consequent loss of hypoxia-inducible factor-1alpha transcriptional antagonist activity.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP170611.RAv31avUsHRXyLBVfESsCgY9_yh_nruMy2KyBQ0mRnd38130_provenance.
- assertion description "[Results show that breast cancer development is characterized by either nuclear loss or cytoplasmic translocation of CITED4, with consequent loss of hypoxia-inducible factor-1alpha transcriptional antagonist activity.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- NP206657.RAJyq3AYntg0TSt0vtCyOgZkI03XscVdO7Z8Hp4r2vKig130_assertion description "[Results show that breast cancer development is characterized by either nuclear loss or cytoplasmic translocation of CITED4, with consequent loss of hypoxia-inducible factor-1alpha transcriptional antagonist activity.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP206657.RAJyq3AYntg0TSt0vtCyOgZkI03XscVdO7Z8Hp4r2vKig130_provenance.